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ABSTRACT
Objective: To assess the level of knowledge, perceptions and usage 
profile for generic drugs among laypersons. Methods: A cross-
sectional study was conducted with 278 volunteers (180 women and 
98 men, aged 37.1±15.8 years). A questionnaire was drawn up with 
questions on their use, perceptions and knowledge of generic drugs. 
Results: Most respondents (99.6%) knew that generic drugs exist, 
but only 48.6% were able to define them correctly, while 78.8% of the 
respondents had some information about generics. This information 
was obtained mainly through television (49.3%). In terms of generic 
drug characteristics, 79.1% stated that they were confident about 
their efficacy, 74.8% believed that generic drugs have the same effect 
as branded medications, 88.8% said that generics were priced lower 
than branded medications, and 80.2% stated that they bought generic 
drugs because of price. With regard to drugs prescribed by medical 
practitioners, 17.6% of the participants said that their doctors never 
prescribed generics and only 7.5% confirmed that their doctors always 
prescribed generics. Conclusion: For the lay public, the sample in this 
study has sufficient knowledge of generic drugs in terms of definition, 
efficacy and cost. Consequently, the volunteers interviewed are very 
likely to use generics. Furthermore, the results of this study indicate 
that programs should be implemented in order to boost generic drug 
prescriptions by medical practitioners.
Keywords: Reference drugs; Generic drugs; Public policies; Drug use; 
Patient education
RESUMO
Objetivo: Avaliar nível de conhecimento, percepções e perfil de 
utilização dos medicamentos genéricos entre leigos. Métodos: 
Realizou-se um estudo transversal com 278 voluntários (180 mulheres 
e 98 homens, com idade de 37,1±15,8 anos). Criou-se um questionário 
com perguntas em relação à utilização, à percepção e ao conhecimento 
sobre genéricos. Resultados: A maioria dos entrevistados (99,6%) 
conhecia a existência dos genéricos, e apenas 48,6% souberam 
definir corretamente o que os mesmos são. Do total de entrevistados, 
78,8% tiveram algum tipo de informação com relação aos genéricos. 
Essas informações foram obtidas, principalmente, por meio da 
televisão (49,3%). Com relação às características dos medicamentos 
genéricos, 79,1% afirmaram ter confiança em sua eficácia, 74,8% 
acreditavam que o medicamento genérico possuía um efeito igual 
ao do medicamento de marca, 88,8% informaram que o genérico 
possuía um preço menor que o medicamento de marca, e 80,2% 
afirmaram comprar o medicamento genérico por conta do preço. 
Quanto à prescrição de medicamentos por parte dos profissionais 
médicos, 17,6% dos participantes afirmaram que seu médico nunca 
prescreveu medicamentos genéricos e apenas 7,5% disseram que 
seus médicos sempre prescreviam genéricos. Conclusão: Para um 
público leigo, a amostra estudada apresentou suficiente conhecimento 
com relação aos genéricos, no que concerne à definição, eficácia 
e custo. Dessa forma, os voluntários entrevistados apresentaram 
elevada propensão à utilização de genéricos. Adicionalmente, os 
resultados deste estudo demonstraram que se faz necessário implantar 
programas para aumentar a prescrição de medicamentos genéricos 
por profissionais médicos.
Descritores: Medicamentos de referência; Medicamentos genéricos; 
Políticas públicas; Uso de medicamentos; Educação do paciente
INTRODUCTION
Drugs play a role in health protection and recovery, in 
addition to helping maintain and enhance the quality 
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of life.(1) Around one third of the world’s population 
encounters difficulties in accessing medications, due to 
high prices, with this proportion rising to 50% in the 
developing countries.(2) Consequently, generic drugs are 
an alternative to reference drugs in many countries all over 
the world, including the United States (USA), Germany, 
United Kingdom, Iraq, Malaysia and Brazil.(3-7) 
A generic drug is defined as a medication that is 
produced freely after expiry of the patent protecting 
the branded product, necessarily being similar to the 
reference drug in bioequivalence in order to obtain 
the same therapeutic effect.(8) The reference drug is 
registered with the federal public health surveillance 
agency, and its quality must be proven scientifically 
when applying for registration, with its efficacy and 
safety being tested through clinical trials.(9) In addition 
to reference and generic drugs, there is a third class called 
“similar drugs”, defined as medications with the same 
active ingredient(s), concentration, pharmaceutical 
form, route of administration, dosage and treatment 
indication, which are equivalent to the medication 
registered with the federal agency, although allowed to 
differ in some characteristics, such as product size and 
shape, use-by dates, packaging, labeling, excipients and 
vehicles.(9) 
In practice, generic and similar drugs are copies of 
the reference drug, with the difference between them 
being the fact that generics use the name of the active 
ingredient, while similar drugs use the commercial name. 
Additionally, since they were first introduced, generic 
drugs have been bound to present bioequivalence tests, 
while this requirement was imposed for similar drugs in 
Brazil only from 2003 onwards. However, by year-end 
2014, all Brazilian similar drugs must provide evidence 
of relative bioavailability.(9)
In Brazil, the introduction of generic drugs (Law 
No. 9,787 promulgated in 1999) resulted in a drop in 
prices between 40% and 62%.(10) However, their sales 
in Brazil account for only 27.1% of the pharmaceutical 
market, although reaching around 80% in the USA.(11) 
Despite the major advantages offered by generic 
drugs, resistance factors have already been described 
in terms of their use, such as: (1) limited availability of 
these products in chemists;(10) (2) weak encouragement 
for their prescription by medical practitioners;(6,12) (3) 
lack of knowledge among healthcare professionals;(13) 
(4) lack of usage guidelines;(14) and (5) lack of knowledge 
and negative beliefs among consumers regarding their 
use. In a study conducted in Spain, Vallès et al.(14) 
showed that 98.8% of patients agreed to switch from 
reference drugs to generics after receiving information 
on the generics. This shows that knowledge about 
generic drugs is a major factor guiding their choice by 
consumers.
In Brazil, outlays on healthcare account for the fourth 
largest group of family expenditures, and outlays on 
medications account for some 48.6% of these expenses.(15) 
The introduction of generic drugs thus became an 
alternative for acquiring good quality medications at 
affordable prices for large segments of the population.
As a result, a cross-sectional study assessing knowledge 
of generic drugs, information received by consumers 
about these medications and consumer usage profiles 
can portray their situation in Brazil, fifteen years after 
the Generic Drugs Act was promulgated, as well as 
aspects still shadowed by doubts among consumers. 
Moreover, this research project can help steer planning 
for public health and health education policies on this 
important issue.
OBJECTIVE
The objective of this study was to investigate knowledge, 
perceptions and use of generic drugs among laypersons. 
METHODS
Subjects
This is a descriptive, cross-sectional study with 278 
subjects (180 women) aged 37.1±15.8 years (range 18.1 
- 89.7 years). The volunteers were recruited through 
direct contacts in public places such as streets and malls, 
in the following Brazilian municipalities: São Paulo 
State - São Paulo (n=124); Osasco (n=6); Guarulhos 
(n=5); Mairiporã (n=2); Carapicuíba (n=1); Diadema 
(n=1); Franco da Rocha (n=1); Itaquaquecetuba 
(n=1); Santos (n=1); Goiás State – Jataí (n=110); Rio 
Verde (n=2); Mineiros (n=1); Quirinópolis (n=1); 
Paraíba State – Patos (n=1); Rio de Janeiro State – Rio 
de Janeiro (n=1); Piauí State – Teresina (n=1), with 
19 not identifying their municipality of origin. In terms 
of healthcare services, 158 (56.8%) of the respondents 
affirmed that they were covered by health insurance 
plans and were treated at private facilities; 105 (37.8%) 
were treated at government health units; 9 (3.2%) had 
no health insurance plan and were treated at public 
and private health units; and 6 (2.1%) stated that they 
had no health insurance plan and were not treated at 
any type of healthcare facility. Table 1 presents the 
additional characteristics of the sample.
Schoolchildren or students aged under 18 years 
and healthcare practitioners were excluded from the 
sample, as well as people with cognitive disorders that 
prevented them from understanding the data collection 
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Table 1. Characteristics of the sample (n=278)
Family income 
(minimum wage) n (%)
Socioeconomic 
class* n (%) Schooling level n (%)
Up to 1 10 (3.6) E 0 (0.0) Primary School – 
incomplete
22 (7.9)
1-2 35 (12.6) D 6 (2.2) Primary School – 
complete
10 (3.6)
2-3 43 (15.5) C2 28 (10.1) Secondary School – 
incomplete
24 (8.6)
3-4 63 (22.7) C1 60 (21.6) Secondary School – 
complete
88 (31.7)
4-5 51 (18.3) B2 106 (38.1) University – 
incomplete
69 (24.8)
5-10 49 (17.6) B1 55 (19.8) University – 
complete
35 (12.6)
10-15 9 (3.2) A2 21 (7.6) Graduate Studies – 
incomplete
5 (1.8)
15-20 18 (6.5) A1 2 (0.7) Graduate Studies – 
complete 
25 (9.0)
* Using the criteria established by the Brazilian Association of Research Companies.(16)
tools. The survey was conducted between March 2012 
and October 2013. All the data collection and analysis 
tools were approved by the Research Ethics Committee 
at the Universidade Federal de Goiás (Protocol No. 
168/2012) compliant with Resolution No. 466/2012 
issued by the Conselho Nacional de Saúde [National 
Health Council]. After a detailed explanation of the 
objectives and procedures, the participants signed the 
Informed Consent Form.
Assessment of knowledge about generic drugs
After an extensive literature review on this topic, a 
questionnaire (Annex 1) was drawn up to assess knowledge 
and perceptions of generic drugs. The questionnaire was 
divided into three parts: (1) personal data, (2) education 
and (3) knowledge about generic drugs, prior experience 
with them, means of acquisition, motives for use and 
reasons explaining their choice or not. 
Statistical analysis 
The data were analyzed through the GraphPad Prism® 
statistics software (Version 5.0, San Diego, USA). 
Descriptive statistics were used to analyze the findings 
(mean, standard deviation and absolute and relative 
frequencies).
RESULTS 
Among the respondents, 277 (99.6%) had already heard 
about generic drugs. Surprisingly, one volunteer stated 
that he/she had never heard about these medications. 
Additionally, 135 respondents (48.6%) correctly defined 
generic drugs and 86 (30.9%) did not know how to 
answer this question. 
Nevertheless, 219 (78.8%) respondents had received 
information on generic drugs. This information was 
obtained through the following means: television (49.3%), 
medical practitioners (18%), pharmacies, from counter 
clerks or pharmacists (39.5%) the internet and newspaper 
articles (7.2%), acquaintances or neighbors (3.6%), radio 
(2.9%), street advertising (1.8%); other healthcare 
practitioners and at universities (0.7%). In terms of use, 
225 (81%) stated that they were taking or had already 
taken generic drugs. 
Regarding the characteristics of generic drugs, 220 
(79.1%) stated that they were confident about their 
efficacy, 208 (74.8%) believed that they had the same 
effects as the reference drugs and 209 (75.2%) believed 
that generic drugs were just as safe as reference drugs. 
However, 40 (14.4%) thought that generic drugs were 
poorer quality than reference drugs and 95 (34.2%) 
would not select the generic instead of reference drug. 
With regard to prescribing medications by physicians, 
49 (17.6%) participants stated that their physicians 
never prescribed generic drugs and only 21 (7.5%) 
said that their physicians always prescribed generics. 
Despite low prescribing among medical practitioners, 48 
volunteers (17.4%) stated that they habitually buy these 
medications, with 62 (22.3%) buying them frequently 
and 107 (38.5%) sometimes.
Among all the respondents, 247 (88.8%) stated that 
generic drugs are less expensive than reference drugs 
and 223 (80.2%) stated that they buy generic drugs 
because of the price. 
When asked “If your physician prescribed a branded 
drug and the pharmacist offered you a cheaper generic, 
would you agree to switch?”, 183 (65.8%) replied that 
they would. When asked “If your physician prescribed a 
branded drug and the pharmacist offered you a generic 
drug for the same price, would you agree to switch?”, 
only 74 (26.6%) replied that they would. With regard to 
the statement “I would switch from a reference drug to 
a generic drug only if the disease was not serious”, 93 
(33.5%) replied positively.
Among the respondents, 157 (56.5%) stated that 
generic drugs had the same substance as reference 
drugs and 140 (50.3%) felt that generic drugs were well 
publicized in Brazil. When asked whether they could 
find generic drugs in pharmacies, 120 (43.2%) stated 
that they always found them.
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DISCUSSION
In Brazil, outlays on medication account for 48.6% 
of expenditures on healthcare.(15) As a result, the 
availability of medications at affordable prices must 
be included in the list of topics addressed by public 
health policies. Some studies assessed compliance with 
the use of generic drugs in Brazil(16,17) and, in the early 
days, due to a lack of knowledge among healthcare 
professionals and the lay population, there was some 
resistance to prescribing and taking them. In order 
to see whether the situation has changed, this study 
explored the perceptions, levels of knowledge and use 
of generic drugs fifteen years after the promulgation of 
Brazil’s Generic Drugs Act, showing that 99.6% of the 
respondents had already heard about them. This finding 
is similar to that obtained in other studies conducted in 
Brazil.(11,17) In a survey conducted in Recife, Pernambuco 
State, da Rocha et al.(17) demonstrated that 95.7% of the 
respondents had heard about generic drugs. In a survey 
conducted by National Health Surveillance Agency 
(ANVISA - Agência Nacional de Vigilância Sanitária), 
95% of consumers stated that they knew about generic 
drugs.(11) Fortunately, the Brazilian context is better 
than that noted in other countries. In a study conducted 
in Auckland, New Zealand, only 51% of the respondents 
had heard of the phrase “generic drug”.(3) Naing et 
al.(18) assessed knowledge of the medications taken 
by the population of Malaysia, noting that 85.8% 
did not know the term “generic drug”, 86.3% did not 
know how to reply on the quality of generic drugs 
compared to reference drugs and 86.9% did not know 
about price differences between generic and reference 
drugs. The good results obtained among the Brazilian 
population can be attributed to awareness-heightening 
and popularization programs for generic drugs, run 
by the Brazilian Government and the pharmaceutical 
companies producing these types of medications.
In this study, 78.8% had obtained information on 
generic drugs: 49.3% from television and 18% from 
physicians. Findings similar to those presented in this 
study were described by Himmel et al., (19) in a study of 
the German population. 
With regard to the definition of a generic drug, 
48.6% of the respondents defined it correctly. In a 
study conducted in Malaysia of 216 people, Thomas 
and Vitry(7) assessed knowledge about generic drugs, 
the wish to take them and the reasons for choice. 
Among the sample assessed, 32.5% stated that they 
knew what generic drugs were. However, when asked to 
provide a more exact definition, 7% (out of the 32.5%) 
were unable to do so. Among them who provided 
this information, 51% said that they were cheaper 
medications, 18% stated that they were “not original” 
or “not genuine”, 18% said that they were medications 
manufactured locally or by a company other than the 
mainstream manufacturer, and 13% said that their 
names were different from a medication with the same 
contents.
In this study, most (79.1%) of the respondents 
believed in efficacy of generics. Finding similar to those 
of our study were obtained by Thomas and Vitry.(7) 
People declaring that they do not believe in the efficacy 
of generic drugs probably do so because of negative 
experience with these medications (lower efficacy, 
compared to reference drugs). However, this effect is 
not exclusive to generics. This may also be blamed on 
inter-individual variations, which is a serious problem 
consisting of a loss of pharmacological efficacy and 
adverse effects. Some of the factors associated with 
the variability of the pharmacological and therapeutic 
effects, are age, pregnancy and the presence of disease.(20) 
In fact, there are situations in which a specific medication 
may present a therapeutic response other than the 
expected outcome or the patient may even be refractory 
to pharmacological treatment in some cases. For example, 
one third of patients with depression are refractory 
to pharmacological treatment.(21) Although some are 
resistant to taking generics, in this study, 80.9% of the 
respondents had already followed this type of treatment. 
These findings cannot be attributed to their prescription 
by physicians as, according to the respondents, only 
7.5% and 13.3% always and frequently prescribe generics, 
respectively. These findings are noteworthy as they 
suggest that the population does not follow medical 
prescriptions, replacing the reference drug by a cheaper 
generic counterpart. In this study, 88.8% stressed that 
the generic is cheaper than the reference drug, 80.2% 
buy the generic drug because of the price and 65.8% 
of the respondents replied positively when asked if 
they would choose the generic over the reference drug. 
Finally, when asked “If your physician prescribed a 
branded drug and the pharmacist offered you a cheaper 
generic, would you agree to switch?”, 65.8% replied that 
they would. This means that the price of generic drugs 
is a decisive factor in patient choices. Confirming this 
statement, when the respondents were asked “If your 
physician prescribed a branded drug and the pharmacist 
offered you a generic drug for the same price, would 
you agree to switch?”, 73.4% replied that they would 
not and when asked “If your physician prescribed a 
reference drug and the pharmacist offered you a more 
expensive generic, would you agree to switch?”, 97.1% 
replied that they would not. In a study conducted 
by Blatt et al.,(6) 34.6% replied that their primary 
physicians never prescribe generics while only 23.5% 
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always prescribe them. Similar findings were obtained by 
García el al.,(13) reporting that only 22% of prescriptions 
had been issued under the generic nomenclature 
established by ANVISA.(12) This fact suggests that the 
awareness of medical doctors should be heightened 
with regard to prescribing generic drugs. 
Blatt et al.(6) conducted a study in order to explore 
the level of knowledge and use of generic drugs among 
people living in the Tubarão municipality, Santa Catarina 
State. To do so, they conducted a cross-sectional study 
with a sample consisting of 234 subjects. In order to 
ascertain the knowledge of these respondents, three 
illustrations of two medications (paracetamol and 
atenolol) were presented. Each medication was shown 
in illustrations corresponding to the reference, generic 
and similar drugs. It was noted that 91.0% of the 
volunteers correctly identified all the figures showing 
generic drugs. This means that the lay population is 
able to recognize generic drugs and consequently, the 
low number of prescriptions issued by physicians, as 
mentioned by the respondents, cannot be blamed on 
possible confusion about the prescribed medication.
Along these lines, studies show that a good step 
for boosting generic prescriptions is to step up the 
level of knowledge among their prescribers.(13,14) Low 
prescription levels for generic drugs can be explained, 
as the dissemination process of reference and similar 
drugs is far more dynamic than that of the generics, due 
to the persuasive tools deployed by the pharmaceutical 
industry, including their sales representatives, who 
divulge basic information and showcase the reference 
drug to medical practitioners.(22) This does not mean 
that generics are not publicized, but rather that this 
occurs less frequently and less intensively, compared to 
similar and reference drugs.(6)
CONCLUSION
The studied population showed that it is endowed with 
sufficient knowledge about generic drugs, in terms of 
definitions, efficacy and cost, and consequently it can be 
proven that the volunteer respondents were very likely 
to take them. Additionally, the findings of this study 
also show that programs must be implemented in order 
to boost generic drug prescriptions among physicians.
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Annex 1. Questionnaire assessing use and knowledge of generic drugs among laypersons
The objective of this study is to assess your knowledge about generic drugs through completing a questionnaire. 
Questionnaire completion date: ___/___/___.
1. Personal Data:
Full Name: ____________________________________________ Number:___________
Date of birth: ___/___/______ Age: _____ years
Sex: (_) M__(_) F__City: ______________State: ___________
Marital status: (_) unmarried__(_) married__(_) divorced__(_) widowed
Occupation: _________________________________________________________
What is the approximate total monthly income of your family? Add your wages to those of your spouse and children (who are still dependent on you).
(_) 1 minimum wage (_) 1-2 minimum wages (_) 2-3 minimum wages
(_) 3-4 minimum wages (_) 4-5 minimum wages (_) 5-10 minimum wages
(_) 10-15 minimum wages (_) 15-20 minimum wages (_) Above 20 minimum wages
With regard to the healthcare services that you use and/or have? 
(_) I have a heath insurance plan and I am treated at private healthcare facilities 
(_) I am treated at public healthcare facilities 
(_) I do not use and/or am not treated by any type of healthcare facility.
2. Education
For how many years did you study?____________
Highest qualifications: 
(_) Primary School – incomplete (_) Primary School – complete (_) Secondary School – incomplete
(_) Secondary School – complete (_) University – incomplete (_) University – complete
(_) Graduate Studies – incomplete Graduate Studies – complete: 
(_) Specialization 
(_) Master's Degree 
(_) PhD
3. General information and knowledge of generic drugs
1. Have you ever heard about generic drugs?__(_) Yes__(_) No.
2. A generic drug can be produced freely, once the branded product patent protection period has expired, and must be similar to the branded drug in order to obtain the same therapeutic 
effect.
Is this information correct?__(_) Yes__(_) No__(_) Don’t Know.
3. Do you take medications for continuous use?
(_) Yes__Which?___________________________(_) No For what disease?________________
If yes, is this medication generic?__(_) Yes__(_) No__(_) Don’t Know.
4. Are you taking any medication at the moment?
(_) Yes Which?_________________________ (_) No For what disease?________________
If yes, is this medication generic?__(_) Yes__(_) No__(_) Don’t Know.
5. What is the quantity of medications that you purchase each month?
(_) 0__(_) 1__(_) 2__(_) 3__(_) 4__(_) 5__(_) more than 5
6. Where do you buy the medication? 
(_) Pharmacy/government healthcare unit (free)__(_) Pharmacy/drugstore (paid)__(_) Free samples handed out by healthcare practitioners in practices, clinics and/or hospitals__
(_) I do not purchase or take medications.
7. How often do you visit a pharmacy/drugstore/government healthcare unit? 
(_) Once a week or more__(_) Once every three months__(_) Once every six months or less__(_) Only when I am sick__(_) I do not visit them.
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Annex 1. Questionnaire assessing use and knowledge of generic drugs among laypersons
8. Have you already received information on generic drugs?__(_) Yes (_) No.
If yes, how did you obtain this information? 
(_) Television__(_) Pharmacy__(_) Physician__(_) Radio__(_) Pharmacist__(_) Pharmacy Counter Clerks__(_) Acquaintances/Neighbors__(_) Advertisement in newspapers/magazines__
(_) University__(_) Street Advertising__(_) Internet__(_) I have never obtained this information__(_) Some other healthcare practitioner. 
Which?_____________________________________________________________
9. Do you trust the efficacy of generic drugs?__(_) Yes__(_) No. 
10. Have you already taken generic drugs?__(_) Yes.__Which? _____________(_) No.
11. Do you identify a generic drug by the substance that it contains?__(_) Yes__(_) No__(_) Don’t know.
12. Has your physician already prescribed/or is prescribing a generic drug for you? 
(_) Never__(_) Rarely__(_) Sometimes__(_) Frequently__(_) Always__(_) Don’t know.
13. Do you usually buy generic drugs? 
(_) Never__(_) Rarely__(_) Sometimes__(_) Frequently__(_) Always__(_) Don’t know.
14. Do you think that the price of the generic drug is...
(_) Less than the branded drug__(_) Same as the branded drug__(_) More than the branded drug__(_) Don’t know.
15. Do you buy or have you bought generic drugs because of the price?__(_) Yes__(_) No.
16. Would you choose a generic drug over a branded drug?__(_) Yes__(_) No.
17. Compared to the branded drug, do you think that the effect of the generic drug is...
( ) Less than the branded drug__(_) Same as the branded drug__(_) More than the branded drug__(_) Don’t know.
18. Compared to the branded drug, do you think that the generic drug is good quality? 
(_) Lower__(_) Same__(_) Better__(_) Don’t know.
19. Compared to the branded drug, do you think that the generic drug is safe? 
(_) Less__(_) Same__(_) More__(_) Don’t know.
20. Compared to the branded drug, do you think that the generic drug has side effects? 
(_) Fewer__(_) Same__(_) More__(_) Don’t know.
21. I would switch from a branded drug to a generic drug only if the disease was not serious (for example: influenza, cold, fever etc.)__(_) True__(_) False. 
22. If your physician prescribed a branded drug and the pharmacist offered you a cheaper generic, would you agree to switch?__(_) Yes__(_) No.
23. If your physician prescribed a branded drug and the pharmacist offered you a generic drug for the same price, would you agree to switch?__(_) Yes__(_) No.
24. If your physician prescribed a branded drug and the pharmacist offered you a more expensive generic drug, would you agree to switch?__(_) Yes__(_) No.
25. Does a generic drug have the same substance as a branded drug?__(_) Yes__(_) No__(_) Don’t know.
26. How often do you take generic drugs? 
(_) Never__(_) Rarely__(_) Sometimes__(_) Frequently__(_) Always__(_) Don’t know.
27. Do you think that generic drugs are well publicized in Brazil?__(_) Yes__(_) No__(_) Don’t know.
28. What is your opinion on the publicity for generic drugs? 
(_) Excellent__(_) Good__(_) Fair__(_) Poor.
29. Can you find generic drugs in pharmacies? 
(_) Never__(_) Rarely__(_) Sometimes__(_) Frequently__(_) Always__(_) Don’t know.
